|
Market Closed -
Nasdaq
08:00:00 14/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 427.39 USD | +0.51% |
|
+6.95% | -26.61% |
| 06/11 | HEALTH ROUNDS-New blood test matches gold standard for liver disease diagnosis | RE |
| 06/11 | Madrigal Pharmaceuticals, Inc. Announces Real-World Data Demonstrating Improvements With Rezdiffra | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDGL | Delayed | |
| MDGL | Real-time | ||
| YDO1 | Delayed | ||
| YDO1 | Real-time | ||
| YDO1 | Delayed | ||
| YDO1 | Real-time | ||
| 1MDGL | End-of-day quote | ||
| YDO1 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 447.09 | 467.54 | 489.31 |
| Spread/Res. | -4.41% | -8.59% | -12.65% |
| Spread/Supp. | +7.84% | +7.84% | +6.95% |
| Support | 396.32 | 396.32 | 399.63 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MDGL Stock
- Charts Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















